# EDGAR Filing Document

**Accession Number:** 0001792126
**File Stem:** 0001172661-25-004028
**Filing Date:** 2025-8
**Character Count:** 28314
**Document Hash:** 21bf03eea5219184f1d047df764ebe84
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001172661-25-004028.hdr.sgml**: 20250829

**ACCESSION NUMBER**: 0001172661-25-004028

**CONFORMED SUBMISSION TYPE**: N-PX

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20250630

**FILED AS OF DATE**: 20250829

**EFFECTIVENESS DATE**: 20250829

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Logos Global Management LP
- **CENTRAL INDEX KEY:** 0001792126

**ORGANIZATION NAME:**
- **EIN:** 833997742
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** N-PX
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 028-20025
- **FILM NUMBER:** 251279472

**BUSINESS ADDRESS:**
- **STREET 1:** 1 LETTERMAN DRIVE
- **STREET 2:** BLDG C, SUITE C3-350
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94129
- **BUSINESS PHONE:** 4158014660

**MAIL ADDRESS:**
- **STREET 1:** 1 LETTERMAN DRIVE
- **STREET 2:** BLDG C, SUITE C3-350
- **CITY:** SAN FRANCISCO
- **STATE:** CA
- **ZIP:** 94129

## FORM N-PX
### ANNUAL REPORT OF PROXY VOTING RECORD

## N-PX: Filer Information

**Filer CIK:** 0001792126

**Date of Report:** 06/30/2025

**Are you a Registered Management Investment Company or an Institutional Manager?:** Institutional Manager

**Is this a LIVE or TEST Filing?:** LIVE

**Is this an electronic copy of an official filing submitted in paper format?:** [ ]

### Submission Contact Information
_Not provided in this filing._

### Notification Information
**Notify via Filing Website only?:** [ ]

## N-PX: Cover Page

**Name of reporting person:** Logos Global Management LP

**Address:** 1 LETTERMAN DRIVE, SAN FRANCISCO, CA 94129

**Telephone number:** 415-801-4677

**Name of agent for service:** —

**Agent Address:** —, —, — —

**Reporting Period:** Report for the year ended 06/30/2025

**SEC File Number:** 028-20025

**CRD Number (if any):** —

**Other SEC File Number (if any):** —

**LEI (if any):** —

**Report Type (check only one):**

Institutional Manager.

- [x] Institutional Manager Voting Report

- [ ] Institutional Manager Notice Report

- [ ] Institutional Manager Combination Report

Registered Management Investment Company.

- [ ] Fund Voting Report

- [ ] Fund Notice Report

**Do you wish to provide explanatory information pursuant to Special Instruction B.4?:**

- [x] No

- [ ] Yes

**Additional information:** —

## N-PX: Summary - Included Managers

**Number of Included Institutional Managers:** 0

**Included Institutional Managers:** —

## FORM N-PX PROXY VOTING RECORD

| NAME OF ISSUER                  | CUSIP     | MEETING DATE   | VOTE DESCRIPTION                                                                                                                                                                                                                | VOTE CATEGORY                |   SHARES VOTED |   SHARES ON LOAN | HOW VOTED   |   SHARES VOTED FOR OR AGAINST MANAGEMENT | FOR OR AGAINST MANAGEMENT   | OTHER INFO   |
|:---|:---|:---|:---|:---|---:|---:|:---|---:|:---|:---|
| LEAP THERAPEUTICS, INC.         | 52187K200 | 07/02/2024     | Advisory vote on executive compensation paid to named executive officers ("Say-on-Pay Proposal").                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          39500 |                0 | AGAINST     |                                    39500 | AGAINST                     |  |
| IMMUNOVANT, INC.                | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         575000 |                0 | FOR         |                                   575000 | FOR                         |  |
| IMMUNOVANT, INC.                | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |         145000 |                0 | FOR         |                                   145000 | FOR                         |  |
| IMMUNOVANT, INC.                | 45258J102 | 08/12/2024     | To approve, on a non-binding, advisory basis, the compensation of our named executive officers.                                                                                                                                 | SECTION 14A SAY-ON-PAY VOTES |            501 |                0 | FOR         |                                      501 | FOR                         |  |
| ATYR PHARMA, INC                | 002120202 | 05/01/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers;                                                                                                                                   | SECTION 14A SAY-ON-PAY VOTES |         800000 |                0 | FOR         |                                   800000 | FOR                         |  |
| VERA THERAPEUTICS, INC.         | 92337R101 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         283131 |                0 | FOR         |                                   283131 | FOR                         |  |
| VERA THERAPEUTICS, INC.         | 92337R101 | 05/14/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.                                                                         | SECTION 14A SAY-ON-PAY VOTES |         283131 |                0 | ONE YEAR    |                                   283131 | FOR                         |  |
| VERA THERAPEUTICS, INC.         | 92337R101 | 05/14/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers, as disclosed in the Proxy Statement.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         406869 |                0 | FOR         |                                   406869 | FOR                         |  |
| VERA THERAPEUTICS, INC.         | 92337R101 | 05/14/2025     | To indicate, on an advisory basis, the preferred frequency of stockholder advisory votes on the compensation of the Company's named executive officers.                                                                         | SECTION 14A SAY-ON-PAY VOTES |         406869 |                0 | ONE YEAR    |                                   406869 | FOR                         |  |
| MERUS N.V.                      | N5749R100 | 05/21/2025     | Approval, on an advisory (non- binding) basis, of the compensation of Merus N.V.'s named executive officers.                                                                                                                    | SECTION 14A SAY-ON-PAY VOTES |         314579 |                0 | FOR         |                                   314579 | FOR                         |  |
| ALKERMES PLC                    | G01767105 | 05/21/2025     | To approve, in a non-binding, advisory vote, the compensation of the Company's named executive officers.                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         149999 |                0 | FOR         |                                   149999 | FOR                         |  |
| GERON CORPORATION               | 374163103 | 05/21/2025     | To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        5000000 |                0 | FOR         |                                  5000000 | FOR                         |  |
| GERON CORPORATION               | 374163103 | 05/21/2025     | To approve, on an advisory basis, the compensation of our Named Executive Officers, as disclosed in our Proxy Statement.                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        2500000 |                0 | FOR         |                                  2500000 | FOR                         |  |
| 89BIO, INC.                     | 282559103 | 05/28/2025     | Approval of, on an advisory basis, the compensation of the Company's named executive officers.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        2750000 |                0 | AGAINST     |                                  2750000 | AGAINST                     |  |
| DYNE THERAPEUTICS, INC.         | 26818M108 | 05/30/2025     | To vote, on an advisory basis, to approve the compensation of our named executive officers.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        1050000 |                0 | AGAINST     |                                  1050000 | AGAINST                     |  |
| DYNE THERAPEUTICS, INC.         | 26818M108 | 05/30/2025     | To hold an advisory vote on the frequency of future advisory votes on the compensation of our named executive officers.                                                                                                         | SECTION 14A SAY-ON-PAY VOTES |        1050000 |                0 | ONE YEAR    |                                  1050000 | FOR                         |  |
| AKERO THERAPEUTICS, INC         | 00973Y108 | 06/03/2025     | To consider and act upon a non- binding, advisory vote to approve the compensation of our named executive officers.                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         415000 |                0 | FOR         |                                   415000 | FOR                         |  |
| AKERO THERAPEUTICS, INC         | 00973Y108 | 06/03/2025     | To consider and act upon a non- binding, advisory vote to approve the compensation of our named executive officers.                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         534655 |                0 | FOR         |                                   534655 | FOR                         |  |
| XENON PHARMACEUTICALS INC       | 98420N105 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Corporation's named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         650000 |                0 | FOR         |                                   650000 | FOR                         |  |
| KEROS THERAPEUTICS, INC.        | 492327101 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement.                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        1600000 |                0 | AGAINST     |                                  1600000 | AGAINST                     |  |
| KEROS THERAPEUTICS, INC.        | 492327101 | 06/04/2025     | To approve, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the accompanying Proxy Statement.                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         400000 |                0 | AGAINST     |                                   400000 | AGAINST                     |  |
| IONIS PHARMACEUTICALS, INC.     | 462222100 | 06/05/2025     | To make an advisory vote on executive compensation.                                                                                                                                                                             | SECTION 14A SAY-ON-PAY VOTES |         450000 |                0 | FOR         |                                   450000 | FOR                         |  |
| ANNEXON, INC.                   | 03589W102 | 06/05/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        1043920 |                0 | FOR         |                                  1043920 | FOR                         |  |
| ANNEXON, INC.                   | 03589W102 | 06/05/2025     | To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers.                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |        2500000 |                0 | FOR         |                                  2500000 | FOR                         |  |
| MOONLAKE IMMUNOTHERAPEUTICS     | 61559X104 | 06/05/2025     | Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         285566 |                0 | FOR         |                                   285566 | FOR                         |  |
| MOONLAKE IMMUNOTHERAPEUTICS     | 61559X104 | 06/05/2025     | Approval of, on a non-binding, advisory basis, the compensation of the Company's named executive officers.                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         264434 |                0 | FOR         |                                   264434 | FOR                         |  |
| GLYCOMIMETICS, INC.             | 38000Q102 | 06/05/2025     | Approve, on an advisory basis, certain compensation arrangements FOR GlycoMimetics' named executive officers that are based on or otherwise relate to the Merger.                                                               | SECTION 14A SAY-ON-PAY VOTES |        4895016 |                0 | FOR         |                                  4895016 | FOR                         |  |
| GLYCOMIMETICS, INC.             | 38000Q102 | 06/05/2025     | Approve, on an advisory basis, the compensation of GlycoMimetics' named executive officers.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        4895016 |                0 | FOR         |                                  4895016 | FOR                         |  |
| GLYCOMIMETICS, INC.             | 38000Q102 | 06/05/2025     | Approve, on an advisory basis, certain compensation arrangements FOR GlycoMimetics' named executive officers that are based on or otherwise relate to the Merger.                                                               | SECTION 14A SAY-ON-PAY VOTES |        5183513 |                0 | FOR         |                                  5183513 | FOR                         |  |
| GLYCOMIMETICS, INC.             | 38000Q102 | 06/05/2025     | Approve, on an advisory basis, the compensation of GlycoMimetics' named executive officers.                                                                                                                                     | SECTION 14A SAY-ON-PAY VOTES |        5183513 |                0 | FOR         |                                  5183513 | FOR                         |  |
| AVIDITY BIOSCIENCES, INC.       | 05370A108 | 06/10/2025     | To consider and vote upon, on an advisory basis, the compensation of our named executive officers as disclosed in this proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission. | SECTION 14A SAY-ON-PAY VOTES |         252806 |                0 | AGAINST     |                                   252806 | AGAINST                     |  |
| OLEMA PHARMACEUTICALS, INC.     | 68062P106 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         640000 |                0 | FOR         |                                   640000 | FOR                         |  |
| OLEMA PHARMACEUTICALS, INC.     | 68062P106 | 06/10/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        1160000 |                0 | FOR         |                                  1160000 | FOR                         |  |
| DISC MEDICINE, INC.             | 254604101 | 06/11/2025     | To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          83405 |                0 | FOR         |                                    83405 | FOR                         |  |
| DISC MEDICINE, INC.             | 254604101 | 06/11/2025     | To recommend, by a non-binding advisory vote, the frequency of future advisory votes on the compensation paid to the Company's named executive officers.                                                                        | SECTION 14A SAY-ON-PAY VOTES |          83405 |                0 | ONE YEAR    |                                    83405 | FOR                         |  |
| DISC MEDICINE, INC.             | 254604101 | 06/11/2025     | To approve, on a non-binding, advisory basis, the compensation paid to the Company's named executive officers.                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |          15000 |                0 | FOR         |                                    15000 | FOR                         |  |
| DISC MEDICINE, INC.             | 254604101 | 06/11/2025     | To recommend, by a non-binding advisory vote, the frequency of future advisory votes on the compensation paid to the Company's named executive officers.                                                                        | SECTION 14A SAY-ON-PAY VOTES |          15000 |                0 | ONE YEAR    |                                    15000 | FOR                         |  |
| ASTRIA THERAPEUTICS, INC.       | 04635X102 | 06/11/2025     | The approval, by non-binding advisory vote, of our executive compensation.                                                                                                                                                      | SECTION 14A SAY-ON-PAY VOTES |         500000 |                0 | FOR         |                                   500000 | FOR                         |  |
| JANUX THERAPEUTICS, INC.        | 47103J105 | 06/11/2025     | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.                                                                           | SECTION 14A SAY-ON-PAY VOTES |         622423 |                0 | FOR         |                                   622423 | FOR                         |  |
| JANUX THERAPEUTICS, INC.        | 47103J105 | 06/11/2025     | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                            | SECTION 14A SAY-ON-PAY VOTES |         622423 |                0 | ONE YEAR    |                                   622423 | FOR                         |  |
| JANUX THERAPEUTICS, INC.        | 47103J105 | 06/11/2025     | Approval, on an advisory basis, of the compensation of our named executive officers ("Say-On-Pay"), as disclosed in the accompanying Proxy Statement.                                                                           | SECTION 14A SAY-ON-PAY VOTES |         827577 |                0 | FOR         |                                   827577 | FOR                         |  |
| JANUX THERAPEUTICS, INC.        | 47103J105 | 06/11/2025     | Indication, on an advisory basis, of the preferred frequency of holding future Say-On-Pay votes on the compensation of our named executive officers.                                                                            | SECTION 14A SAY-ON-PAY VOTES |         827577 |                0 | ONE YEAR    |                                   827577 | FOR                         |  |
| OCULAR THERAPEUTIX, INC.        | 67576A100 | 06/11/2025     | To approve an advisory vote on named executive officer compensation.                                                                                                                                                            | SECTION 14A SAY-ON-PAY VOTES |        2446328 |                0 | AGAINST     |                                  2446328 | AGAINST                     |  |
| XENCOR, INC.                    | 98401F105 | 06/12/2025     | To approve, on an advisory (non- binding) basis, the compensation of the Company's named executive officers, as disclosed in the accompanying Proxy Statement.                                                                  | SECTION 14A SAY-ON-PAY VOTES |         328257 |                0 | FOR         |                                   328257 | FOR                         |  |
| COMPASS PATHWAYS PLC            | 20451W101 | 06/12/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers FOR the year ended December 31, 2024.                                                                                  | SECTION 14A SAY-ON-PAY VOTES |        1999998 |                0 | AGAINST     |                                  1999998 | AGAINST                     |  |
| NUVALENT, INC.                  | 670703107 | 06/18/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |          75077 |                0 | FOR         |                                    75077 | FOR                         |  |
| NUVALENT, INC.                  | 670703107 | 06/18/2025     | To approve, on an advisory basis, the compensation paid to our named executive officers.                                                                                                                                        | SECTION 14A SAY-ON-PAY VOTES |         469962 |                0 | FOR         |                                   469962 | FOR                         |  |
| BLUEPRINT MEDICINES CORPORATION | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |          50000 |                0 | FOR         |                                    50000 | FOR                         |  |
| BLUEPRINT MEDICINES CORPORATION | 09627Y109 | 06/18/2025     | Approval of a non-binding advisory vote on the compensation paid to our named executive officers.                                                                                                                               | SECTION 14A SAY-ON-PAY VOTES |         108724 |                0 | FOR         |                                   108724 | FOR                         |  |
| STRUCTURE THERAPEUTICS, INC.    | 86366E106 | 06/23/2025     | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         187934 |                0 | FOR         |                                   187934 | FOR                         |  |
| STRUCTURE THERAPEUTICS, INC.    | 86366E106 | 06/23/2025     | TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.                                                                         | SECTION 14A SAY-ON-PAY VOTES |         187934 |                0 | ONE YEAR    |                                   187934 | FOR                         |  |
| STRUCTURE THERAPEUTICS, INC.    | 86366E106 | 06/23/2025     | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS, AS DISCLOSED IN THE PROXY STATEMENT.                                                                                              | SECTION 14A SAY-ON-PAY VOTES |         188066 |                0 | FOR         |                                   188066 | FOR                         |  |
| STRUCTURE THERAPEUTICS, INC.    | 86366E106 | 06/23/2025     | TO INDICATE, ON AN ADVISORY BASIS, THE PREFERRED FREQUENCY OF SHAREHOLDER ADVISORY VOTES ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS.                                                                         | SECTION 14A SAY-ON-PAY VOTES |         188066 |                0 | ONE YEAR    |                                   188066 | FOR                         |  |
| IDEAYA BIOSCIENCES, INC.        | 45166A102 | 06/24/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.                        | SECTION 14A SAY-ON-PAY VOTES |         434417 |                0 | AGAINST     |                                   434417 | AGAINST                     |  |
| IDEAYA BIOSCIENCES, INC.        | 45166A102 | 06/24/2025     | To approve, on a non-binding, advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement accompanying this Notice of Annual Meeting of Stockholders.                        | SECTION 14A SAY-ON-PAY VOTES |        2120698 |                0 | AGAINST     |                                  2120698 | AGAINST                     |  |
| Olema Oncology                  | 68062P106 | 06/09/2025     | Approval, on an advisory basis, of the compensation of the Company's named executive officers.                                                                                                                                  | SECTION 14A SAY-ON-PAY VOTES |         708114 |                0 | FOR         |                                   708114 | FOR                         |  |

## N-PX: Signature Block

**Reporting Person:** Logos Global Management LP

**By (Signature):** Derek Gould

**By (Printed Signature):** Derek Gould

**By (Title):** GC/CCO

**Date:** 08/29/2025